(Q40966090)

25 September 2017

title

An epidemiologic reassessment of lipoprotein(a) and atherothrombotic risk (English)

1 reference

25 September 2017

P. M. Ridker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21232264

22 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21232264

22 November 2024

publication date

1 November 1995

1 reference

25 September 2017

November 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21232264

full work available at URL

22 November 2024

https://api.elsevier.com/content/article/PII:1050173895001034?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

https://api.elsevier.com/content/article/PII:1050173895001034?httpAccept=text/plain

22 November 2024

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Trends in Cardiovascular Medicine

22 November 2024

published in

1 reference

25 September 2017

volume

5

1 reference

25 September 2017

issue

6

1 reference

25 September 2017

page(s)

225-229

1 reference

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

25 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein(a) in the arterial wall

22 November 2024

2

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM

22 November 2024

3

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

22 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

22 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

22 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation

22 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

22 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease

22 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy

22 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

22 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Serum lipid changes following the completed stroke syndrome

22 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease.

22 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

22 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis

22 November 2024

20

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein Lp(a) and the risk for myocardial infarction

22 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

22 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).

22 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein(a), fibrin binding, and plasminogen activation.

22 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Transient changes of serum lipoprotein(a) as an acute phase protein

22 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

22 November 2024

26

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

A potential basis for the thrombotic risks associated with lipoprotein(a).

22 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Serum lipids after stroke

22 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction

22 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease

22 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein(a) and risks of cardiovascular disease

22 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

A prospective study of lipoprotein(a) and the risk of myocardial infarction

22 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Plasma concentration of lipoprotein(a) and the risk of future stroke

22 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

22 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein(a). A genetic risk factor for premature coronary heart disease

22 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

22 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities

22 November 2024

39

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction

22 November 2024

40

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men

22 November 2024

41

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo study

22 November 2024

44

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein(a) and acute-phase proteins in acute myocardial infarction

22 November 2024

45

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study

22 November 2024

46

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

The mysteries of lipoprotein(a)

22 November 2024

47

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

22 November 2024

48

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Apolipoproteins and ischaemic heart disease: implications for screening

22 November 2024

49

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Acute and long-term changes in serum lipids after acute stroke

22 November 2024

50

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

Lipoprotein(a) as a strong indicator for cerebrovascular disease

22 November 2024

51

1 reference

https://api.crossref.org/works/10.1016/1050-1738(95)00103-4

22 November 2024

Identifiers

1 reference

release_qcnelepvvbfhzeynux57kwqrgy

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qcnelepvvbfhzeynux57kwqrgy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference